OTC Pharmaceuticals - Tunisia

  • Tunisia
  • The OTC Pharmaceuticals market in Tunisia is projected to generate a revenue of US$216.50m by 2024.
  • With an expected annual growth rate of 4.39% (CAGR 2024-2029), the market shows promising potential.
  • Among the various markets within the market, the Other OTC Pharmaceuticals market holds the largest market share, with a volume of US$70.05m in 2024.
  • In terms of global comparison, the in the United States leads the pack in revenue generation, reaching a staggering US$41,240.00m in 2024.
  • This highlights the dominance of the US market in the OTC Pharmaceuticals market industry.
  • When considering the revenue generated per person, in Tunisia records a figure of US$17.23 in 2024.
  • This indicates the average revenue generated by each individual in relation to the country's total population.
  • Furthermore, the OTC Pharmaceuticals market is expected to witness a shift towards online sales, which are projected to contribute 1.75% of the total revenue by 2024.
  • This demonstrates the increasing importance of e-commerce in the pharmaceutical sector.
  • Tunisia's OTC Pharmaceuticals market is witnessing a surge in demand for traditional herbal remedies.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Tunisia is experiencing steady growth due to changing customer preferences, emerging market trends, and local special circumstances. Customer preferences in Tunisia are shifting towards self-medication and convenience. Consumers are increasingly seeking over-the-counter (OTC) medications for minor ailments and common health issues. This is driven by the desire for quick relief and cost savings, as OTC medications are generally more affordable than prescription drugs. Additionally, the convenience of purchasing OTC medications without a prescription appeals to busy consumers who prefer to avoid doctor visits for minor health concerns.Trends in the OTC Pharmaceuticals market in Tunisia are influenced by global and regional market developments. One notable trend is the increasing availability of OTC medications online. E-commerce platforms and online pharmacies are gaining popularity in Tunisia, providing consumers with easy access to a wide range of OTC products. This trend is driven by the growing internet penetration and the convenience of online shopping. Furthermore, the COVID-19 pandemic has accelerated the adoption of online purchasing, as consumers seek to minimize physical contact and adhere to social distancing measures.Local special circumstances also contribute to the development of the OTC Pharmaceuticals market in Tunisia. The country's healthcare system is characterized by limited access to healthcare facilities, particularly in rural areas. This creates a greater reliance on self-medication and OTC medications for primary healthcare needs. Additionally, the high cost of prescription drugs and the lack of comprehensive health insurance coverage make OTC medications a more affordable option for many Tunisians.Underlying macroeconomic factors further support the growth of the OTC Pharmaceuticals market in Tunisia. The country has experienced stable economic growth in recent years, leading to an increase in disposable incomes. This allows consumers to allocate a portion of their budget towards healthcare expenses, including OTC medications. Furthermore, the government's efforts to improve healthcare infrastructure and promote primary healthcare services contribute to the accessibility and availability of OTC medications.In conclusion, the OTC Pharmaceuticals market in Tunisia is developing due to changing customer preferences, emerging market trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the availability of OTC medications online, limited access to healthcare facilities, and stable economic growth all play a role in driving the growth of this market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)